FDA gives tentative nod for Perrigo’s generic Sernivo sprayBetamethasone dipropionate had a market value of about $15 million for the 12 months ending February 2019, according to IQVIA. Sandoz launches generic RemodulinSandoz will collaborate with RareGen to commercialize its generic Remodulin (treprostinil injection). Novartis completes Alcon spin-off Novartis’ spin-off of the Alcon eye care business will allow the company to focus its attention on medicines. Bartell offers vaccinations, education for international travelers Bartell Drugs' travel clinics, which are now available at 57 of its locations, offers travelers a customized plan for any destination. Fresenius Kabi unveils adenosine injection in prefilled syringes Fresenius Kabi is the first company to offer adenosine in both vials and prefilled syringes. ANI Pharmaceuticals launches 2 generics Methylphenidate hydrochloride extended-release tablets have a market value of roughly $505 million, and erythromycin ethylsuccinate for oral suspension has a market value of $16 million. CBD who’s who: ZuRI CBD Supply ZuRI offers more than 70 SKUs of CBD products, including wellness drops, topicals and pet items. CBD who’s who: Uleva Products Uleva Products offers full-spectrum hemp extract herbal supplements rich in phytocannabinoids to help support the body’s endocannabinoid system. Armas Pharmaceuticals launches 2 generics Armas Pharmaceuticals is introducing generic Xeloda and Gleevec, which had a market value of roughly $108 million and $655 million, respectively. FDA approves reintroduction of Sloan Pharma's Zelnorm Zelnorm was originally approved by the FDA in 2002 for the treatment of IBS-C in women First Previous 483 484 485 486 487 Next Last
